Paper19258929
Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
Press RR and 7 others. Ther Drug Monit, 2009. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. Papers, record 19258929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19258929
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Kidney Transplantation | Major topic |
| Tacrolimus | Major topic |
| Adult | |
| Area Under Curve | |
| Body Weight | |
| Cytochrome P-450 CYP3A | |
| Demography | |
| Drug Administration Schedule | |
| Drug Monitoring | |
| Female | |
| Hematocrit | |
| Humans | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged | |
| Polymorphism, Genetic | |
| Prednisolone | |
| Pregnane X Receptor | |
| Prospective Studies | |
| Randomized Controlled Trials as Topic | |
| Receptors, Steroid | |
| Serum Albumin |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42477302 | A Review of Population Pharmacokinetic Models and Dosing Algorithms Assessing the Influence of CYP3A5 Genotype and Other Clinical Covariates on Tacrolimus Pharmacokinetics. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42477302 | PubMed |
| 41673983 | Accelerating tacrolimus model-informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41673983 | PubMed |
| 40936106 | Refining tacrolimus dosing through CYP3A5 pharmacogenetics in Taiwanese renal transplant recipients. | Ren Fail | 2025 | https://conductscience.org/library/papers/40936106 | PubMed |
| 40709926 | Tacrolimus Exposure is Associated with Acute Rejection in the Early Phase After Kidney Transplantation: A Joint Modeling Approach. | Ther Drug Monit | 2025 | https://conductscience.org/library/papers/40709926 | PubMed |
| 40632895 | Effect of CYP3A4 Methylation on Tacrolimus Pharmacokinetics. | Ther Drug Monit | 2025 | https://conductscience.org/library/papers/40632895 | PubMed |
| 40588615 | A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40588615 | PubMed |
| 40104905 | The tacrolimus concentration-to-dose ratio is associated with kidney function in heart transplant recipients. | Br J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/40104905 | PubMed |
| 39390741 | Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients. | Br J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39390741 | PubMed |
| 39304577 | Model-Informed Precision Dosing of Tacrolimus: A Systematic Review of Population Pharmacokinetic Models and a Benchmark Study of Software Tools. | Clin Pharmacokinet | 2024 | https://conductscience.org/library/papers/39304577 | PubMed |
| 38994750 | Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes. | Br J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38994750 | PubMed |
| 38276495 | Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38276495 | PubMed |
| 37261481 | Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review. | Eur J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/37261481 | PubMed |
| 36239542 | Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients. | Br J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/36239542 | PubMed |
| 35567629 | Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients. | Eur J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/35567629 | PubMed |
| 35020971 | Predicting model-informed precision dosing: A test-case in tacrolimus dose adaptation for kidney transplant recipients. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35020971 | PubMed |
| 34511980 | Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis. | Pharmgenomics Pers Med | 2021 | https://conductscience.org/library/papers/34511980 | PubMed |
| 33649515 | Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients. | Pharmacogenomics J | 2021 | https://conductscience.org/library/papers/33649515 | PubMed |
| 33512723 | Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry. | J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33512723 | PubMed |
| 33452682 | Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33452682 | PubMed |
| 33025649 | Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33025649 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
| NR1I2 | 8856 | PubTator's text mining | https://conductscience.org/library/genes/8856 | NCBI Gene |
| RXRA | 6256 | PubTator's text mining | https://conductscience.org/library/genes/6256 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19258929
GET https://conductscience.org/api/papers/v1/19258929/cited_by?page=2